Skip to main content
. 2024 Nov 13;22:153. doi: 10.1186/s12961-024-01236-1

Table 2.

ICCRT outputs and policy references by theme and phase of pandemic

Outputs N = 620 Phase 1 N = 273 Phase 2 N = 347 Pearson χ2 (P value) Policy reference N = 1746 Phase 1 N = 1099 Phase 2 N = 647 Pearson χ2 (P value)
n (%) n (%) n (%) n (%) n (%) n (%)
Severity/HC demand and capacity 123 (19.8) 54 (19.8) 69 (19.9) 0.001 (0.974) 269 (15.4) 218 (19.8) 51 (7.9) 44.650 (< 0.001)*
Non-pharmaceutical interventions (NPIs) 96 (15.5) 42 (15.4) 54 (15.6) 0.004 (0.952) 453 (25.9) 342 (31.1) 111 (17.2) 41.325 (< 0.001)*
Surveillance/testing 90 (14.5) 38 (13.9) 52 (15.0) 0.140 (0.708) 147 (8.4) 84 (7.6) 63 (9.7) 2.316 (0.128)
Variants/genomics 82 (13.2) 21 (7.7) 61 (17.6) 13.014 (< 0.001)* 264 (15.1) 63 (5.7) 201 (31.1) 203.658 (< 0.001)*
Transmission 48 (7.7) 27 (9.9) 21 (6.1) 3.151 (0.076) 102 (5.8) 52 (4.7) 50 (7.7) 6.647 (0.010)*
Secondary impact 44 (7.1) 24 (8.8) 20 (5.8) 2.124 (0.145) 187 (10.7) 99 (9.0) 88 (13.6) 8.984 (0.003)*
Vaccines 32 (5.2) 5 (1.8) 27 (7.8) 11.049 (< 0.001)* 66 (3.8) 28 (2.5) 38 (5.9) 12.382 (< 0.001)*
Outbreak scale/under-ascertainment 28 (4.5) 24 (8.8) 4 (1.2) 20.674 (< 0.001)* 134 (7.7) 118 (10.7) 16 (2.5) 39.252 (< 0.001)*
Health systems/policy 19 (3.1) 6 (2.2) 13 (3.7) 1.233 (0.267) 14 (0.8) 5 (0.5) 9 (1.4) 4.486 (0.034)*
Other 18 (2.9) 11 (4.0) 7 (2.0) 2.194 (0.139) 7 (0.4) 5 (0.5) 2 (0.3) 0.217 (1.000)^
Behaviour/mobility 16 (2.6) 11 (4.0) 5 (1.4) 4.072 (0.044)* 80 (4.6) 71 (6.5) 9 (1.4) 23.938 (< 0.001)*
Clinical/treatment 13 (2.1) 6 (2.2) 7 (2.0) 0.024 (0.876) 12 (0.7) 11 (1.0) 1 (0.2) 4.274 (0.039)*
Economics 11 (1.8) 4 (1.5) 7 (2.0) 0.267 (0.605) 11 (0.6) 3 (0.3) 8 (1.2) 6.039 (0.014)*

* Significant (P < 0.05), ^Fisher’s exact test considering outputs published in one theme compared to all other outputs and the difference between the two phases